IRCT201103156072N1
Completed
Phase 2
Evaluation of the effect of Alfa lipoic acid, Vitamin E supplementation and their combination on oxidative stress, lipid profile, insulin resistance, inflammation and nutritional status in patients on hemodialysis, Shiraz, 2010
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- End stage of renal disease (hemodialysis).
- Sponsor
- Shiraz University of Medical Sciences
- Enrollment
- 96
- Status
- Completed
- Last Updated
- 8 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •age 20\-60 years, hemodialysis, twice a week, undergoing maintenance hemodialysis for more than 1 year, no receiving antioxidant supplements such as VitE, VitC, or fish oil
- •Exclusion criteria: smoking, pregnancy, presence of acute inflammatory and infectious diseases, presence of liver or Rheumatic diseases (such as lupus,...), cardiac diseases, or cancer, use of anticoagulants or contraceptives thyroxin
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 3
Effects of alpha lipoic acid on ß- Thalassemia Majorß-thalassemia Major.Beta thalassaemiaIRCT2017061714237N2Kermanshah University of Medical Sciences30
Not yet recruiting
Phase 4
Management of Burning Mouth in Type II-Diabetes MellitusCTRI/2020/01/022786S Rajkumari
Completed
Not Applicable
To evaluate the effect of Alpha lipoic acid on platelet aggregation in diabetic neuropathy patientsCTRI/2022/02/040276Indian council of Medical Research52
Completed
Not Applicable
Effect of Alpha Lipoic Acid on neuropathy symptoms and inhibition of platelet aggregation in Diabetic Neuropathy patientsHealth Condition 1: E114- Type 2 diabetes mellitus with neurological complicationsCTRI/2021/10/037068Indian Council of Medical Research52
Recruiting
Phase 3
The effect of an antioxidant on couple fertility with recurrent abortioIRCT20181030041503N4Mashhad University of Medical Sciences40